{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:05:29Z","timestamp":1788869129803,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>Non-acute subdural hematoma (NASDH) is a prevalent neurological condition, encompassing chronic and subacute types. Despite standard-care, including surgical evacuation and medical management, recurrence rates remain high. Emerging evidence suggests that middle meningeal artery embolization (MMAE) as an adjunctive procedure may reduce recurrence. This study evaluates the efficacy and safety of MMAE in NASDH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of randomized controlled trials (RCTs) retrieved from PubMed, EMBASE, WOS, Scopus, and Cochrane until November 2024. The analysis presented risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, with 95% confidence intervals (CI) using R software. The GRADE system assessed evidence certainty, alongside trial sequential analysis for result reliability. PROSPERO ID: CRD42024625504.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six RCTs and 1,544 patients were included, with an average of 4.7\u00a0months follow-up. Adjunctive MMAE, compared to standard-care, significantly reduced hematoma recurrence (8% vs 15.6%; RR: 0.52; 95% CI: [0.37:0.73];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) and surgical rescue (4.5% vs. 12.7%; RR: 0.36; 95% CI: [0.25:0.53];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). However, no significant effect was found for recurrence without surgery (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.94), hematoma volume (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.18), thickness (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.34), or hospital stay (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.37). Infection rates were higher with MMAE (8.4% vs. 4.8%; RR: 1.81; 95% CI: [1.23:2.66];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), but adverse events (AEs), serious AEs, intracranial hemorrhage, stroke, and mortality showed no significant differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adjunctive MMAE reduced hematoma recurrence and surgical rescue rates in NASDH with an acceptable safety profile despite increased infection rates. However, further large-scale trials with extended follow-ups are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00701-025-06574-9","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:45:59Z","timestamp":1748839559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adjunctive middle meningeal artery embolization for non-acute subdural hematoma: A GRADE-assessed meta-analysis and trial sequential analysis on randomized trials"],"prefix":"10.1007","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-2875","authenticated-orcid":false,"given":"Mohamed S.","family":"Elgendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam I.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Meshref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Elewidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuelazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"6574_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2024.104143","volume":"4","author":"J Bartek","year":"2024","unstructured":"Bartek J, Biondi A, Bonhomme V, Castellan L, Catapano G, Cenzato M et al (2024) Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH). Brain and Spine 4:104143. https:\/\/doi.org\/10.1016\/j.bas.2024.104143","journal-title":"Brain and Spine"},{"issue":"8","key":"6574_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/neurintsurg-2021-018327","volume":"14","author":"JS Catapano","year":"2022","unstructured":"Catapano JS, Koester SW, Srinivasan VM, Rumalla K, Baranoski JF, Rutledge C et al (2022) Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. J Neurointerv Surg 14(8):804\u2013806. https:\/\/doi.org\/10.1136\/neurintsurg-2021-018327","journal-title":"J Neurointerv Surg"},{"issue":"20","key":"6574_CR3","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa2313472","volume":"391","author":"JM Davies","year":"2024","unstructured":"Davies JM, Knopman J, Mokin M, Hassan AE, Harbaugh RE, Khalessi A et al (2024) Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med [Internet] 391(20):1890\u20131900. https:\/\/doi.org\/10.1056\/NEJMoa2313472","journal-title":"N Engl J Med [Internet]"},{"key":"6574_CR4","doi-asserted-by":"publisher","first-page":"110783","DOI":"10.1016\/j.jocn.2024.110783","volume":"128","author":"LH Debs","year":"2024","unstructured":"Debs LH, Vale FL, Walker S, Toro D, Mansouri S, Macomson SD et al (2024) Middle meningeal artery embolization following surgical evacuation of symptomatic chronic subdural hematoma improves outcomes, interim results of a prospective randomized trial. J Clin Neurosci 128:110783. https:\/\/doi.org\/10.1016\/j.jocn.2024.110783","journal-title":"J Clin Neurosci"},{"key":"6574_CR5","doi-asserted-by":"publisher","unstructured":"D\u00e9sir LL, D\u2019Amico R, Link T, Silva D, Ellis JA, Doron O, et al. Middle meningeal artery embolization and the treatment of a chronic subdural hematoma. Cureus. 2021;13(10).\u00a0https:\/\/doi.org\/10.7759\/cureus.18868","DOI":"10.7759\/cureus.18868"},{"key":"6574_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0881-y","volume":"14","author":"E Edlmann","year":"2017","unstructured":"Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 14:1\u201313. https:\/\/doi.org\/10.1186\/s12974-017-0881-y","journal-title":"J Neuroinflammation"},{"key":"6574_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/jnis-2024-022158","volume":"16","author":"KM Fargen","year":"2024","unstructured":"Fargen KM, Kan P (2024) Middle meningeal artery embolization, chronic subdural hematomas, and trials: considerations as we move forward. J Neurointerven Surgery Br Med J Publishing Group 16:747\u20139. https:\/\/doi.org\/10.1136\/jnis-2024-022158","journal-title":"J Neurointerven Surgery Br Med J Publishing Group"},{"key":"6574_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.wneu.2020.06.140","volume":"141","author":"J Feghali","year":"2020","unstructured":"Feghali J, Yang W, Huang J (2020) Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 141:339\u2013345. https:\/\/doi.org\/10.1016\/j.wneu.2020.06.140","journal-title":"World Neurosurg"},{"key":"6574_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409845","author":"D Fiorella","year":"2024","unstructured":"Fiorella D, Monteith SJ, Hanel R, Atchie B, Boo S, McTaggart RA et al (2024) Embolization of the middle meningeal artery for chronic subdural hematoma. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2409845","journal-title":"N Engl J Med"},{"issue":"7650","key":"6574_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"issue":"6","key":"6574_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1227\/neu.0000000000002144","volume":"91","author":"J Henry","year":"2022","unstructured":"Henry J, Amoo M, Kissner M, Deane T, Zilani G, Crockett MT et al (2022) Management of chronic subdural hematoma: a systematic review and component network meta-analysis of 455 studies with 103 645 cases. Neurosurgery 91(6):842\u2013855. https:\/\/doi.org\/10.1227\/neu.0000000000002144","journal-title":"Neurosurgery"},{"key":"6574_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (eds) (2024) Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). [Internet]. Cochrane. Available from www.training.cochrane.org\/handbook. Accessed 22 November 2024"},{"key":"6574_CR13","doi-asserted-by":"publisher","first-page":"159101992413048","DOI":"10.1177\/15910199241304852","volume":"12","author":"H Hoffman","year":"2024","unstructured":"Hoffman H, Sims JJ, Nickele C, Inoa V, Elijovich L, Goyal N (2024) Middle meningeal artery embolization with standalone or adjunctive coiling for treatment of chronic subdural hematoma: Systematic review and meta-analysis. Interv Neuroradiol. 12:15910199241304852. https:\/\/doi.org\/10.1177\/15910199241304852","journal-title":"Interv Neuroradiol."},{"key":"6574_CR14","doi-asserted-by":"publisher","first-page":"e868","DOI":"10.1016\/j.wneu.2024.08.026","volume":"190","author":"A Hung","year":"2024","unstructured":"Hung A, Das O, Kalluri A, Wang X, Ran K, Ejimogu E et al (2024) Cost savings on inpatient hospitalization for middle meningeal artery embolization in the setting of increased case volume and low complications rate. World Neurosurg 190:e868\u2013e873. https:\/\/doi.org\/10.1016\/j.wneu.2024.08.026","journal-title":"World Neurosurg"},{"key":"6574_CR15","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.clineuro.2024.108572","volume":"246","author":"P Jagtiani","year":"2024","unstructured":"Jagtiani P, Karbacak M, Coomar P, Margetis K (2024) Middle Meningeal Artery Embolization versus Conventional Management for Patients with Chronic Subdural Hematoma: An Umbrella Review. Clin Neurol Neurosurg 246:108572. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108572","journal-title":"Clin Neurol Neurosurg"},{"key":"6574_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.25259\/SNI_208_2023","volume":"14","author":"A Lam","year":"2023","unstructured":"Lam A, Selvarajah D, San Htike S, Chan S, Lalloo S, Lock G et al (2023) The efficacy of postoperative middle meningeal artery embolization on chronic subdural hematoma\u2013A multicentered randomized controlled trial. Surg Neurol Int 14:168. https:\/\/doi.org\/10.25259\/SNI_208_2023","journal-title":"Surg Neurol Int"},{"issue":"4","key":"6574_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1591019918769336","volume":"24","author":"TW Link","year":"2018","unstructured":"Link TW, Rapoport BI, Paine SM, Kamel H, Knopman J (2018) Middle meningeal artery embolization for chronic subdural hematoma: endovascular technique and radiographic findings. Interv Neuroradiol 24(4):455\u2013462. https:\/\/doi.org\/10.1177\/1591019918769336","journal-title":"Interv Neuroradiol"},{"issue":"20","key":"6574_CR18","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa2401201","volume":"391","author":"J Liu","year":"2024","unstructured":"Liu J, Ni W, Zuo Q, Yang H, Peng Y, Lin Z et al (2024) Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med 391(20):1901\u20131912. https:\/\/doi.org\/10.1056\/NEJMoa2401201","journal-title":"N Engl J Med"},{"key":"6574_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1227\/ons.0000000000000794","volume":"25","author":"R Lodewijkx","year":"2022","unstructured":"Lodewijkx R, Foppen M, Slot KAM, Vandertop WP, Verbaan D (2022) Recurrent chronic subdural hematoma after burr-hole surgery and postoperative drainage: a systematic review and meta-analysis. Oper Neurosurg. 25:10\u20131227. https:\/\/doi.org\/10.1227\/ons.0000000000000794","journal-title":"Oper Neurosurg."},{"issue":"1","key":"6574_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s10143-023-02175-1","volume":"46","author":"SF Maroufi","year":"2023","unstructured":"Maroufi SF, Farahbakhsh F, Macdonald RL, Khoshnevisan A (2023) Risk factors for recurrence of chronic subdural hematoma after surgical evacuation: a systematic review and meta-analysis. Neurosurg Rev 46(1):270. https:\/\/doi.org\/10.1007\/s10143-023-02175-1","journal-title":"Neurosurg Rev"},{"key":"6574_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2018.01.050","volume":"50","author":"V Mehta","year":"2018","unstructured":"Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ (2018) Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature. J Clin Neurosci 50:7\u201315. https:\/\/doi.org\/10.1016\/j.jocn.2018.01.050","journal-title":"J Clin Neurosci"},{"issue":"7","key":"6574_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/neurintsurg-2019-015421","volume":"12","author":"S Ng","year":"2020","unstructured":"Ng S, Derraz I, Boetto J, Dargazanli C, Poulen G, Gascou G et al (2020) Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg 12(7):695\u2013699. https:\/\/doi.org\/10.1136\/neurintsurg-2019-015421","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"6574_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"6574_CR24","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00701-020-04398-3","volume":"162","author":"M Rauhala","year":"2020","unstructured":"Rauhala M, Hel\u00e9n P, Huhtala H, Heikkil\u00e4 P, Iverson GL, Niskakangas T et al (2020) Chronic subdural hematoma\u2014incidence, complications, and financial impact. Acta Neurochir (Wien) 162:2033\u20132043. https:\/\/doi.org\/10.1007\/s00701-020-04398-3","journal-title":"Acta Neurochir (Wien)"},{"key":"6574_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-031-28202-7_10","volume":"46","author":"S Sa\u011f\u0131ro\u011flu","year":"2023","unstructured":"Sa\u011f\u0131ro\u011flu S, Turgut M (2023) Subdural hematomas in adults and children. Adv Tech Stand Neurosurg 46:193\u2013203. https:\/\/doi.org\/10.1007\/978-3-031-28202-7_10","journal-title":"Adv Tech Stand Neurosurg"},{"issue":"6","key":"6574_CR26","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1227\/neu.0000000000002365","volume":"92","author":"SA Sattari","year":"2023","unstructured":"Sattari SA, Yang W, Shahbandi A, Feghali J, Lee RP, Xu R et al (2023) Middle meningeal artery embolization versus conventional management for patients with chronic subdural hematoma: a systematic review and meta-analysis. Neurosurgery 92(6):1142\u20131154. https:\/\/doi.org\/10.1227\/neu.0000000000002365","journal-title":"Neurosurgery"},{"issue":"3","key":"6574_CR27","doi-asserted-by":"publisher","first-page":"108580","DOI":"10.1016\/j.clineuro.2024.108580","volume":"2024","author":"M Shakir","year":"2024","unstructured":"Shakir M, Irshad HA, Alidina Z, Shaikh T, Ashfaq D, Ali Z et al (2024) Middle Meningeal Artery Embolization (MMAE) alone versus combined with conventional surgery in the management of chronic subdural hematoma (cSDH): a systematic review and meta-analysis. Clin Neurol Neurosurg. 2024(3):108580. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108580","journal-title":"Clin Neurol Neurosurg."},{"key":"6574_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28:366. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"12","key":"6574_CR29","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1097\/js9.0000000000000699","volume":"109","author":"X Tong","year":"2023","unstructured":"Tong X, Xue X, Liu A, Qi P (2023) Comparative study on clinical outcomes and cost-effectiveness of chronic subdural hematomas treated by middle meningeal artery embolization and conventional treatment: a national cross-sectional study. Int J Surg 109(12):3836\u20133847. https:\/\/doi.org\/10.1097\/js9.0000000000000699","journal-title":"Int J Surg"},{"key":"6574_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C (2017) Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17:1\u201318. https:\/\/doi.org\/10.1186\/s12874-017-0315-7","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"6574_CR31","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s10143-024-03107-3","volume":"47","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lim JX, Wen D, Wong CP, Lim WEH, Chia GS (2024) Adjunct middle meningeal artery embolization versus surgery for chronic subdural hematoma: a systematic review and meta-analysis. Neurosurg Rev 47(1):876. https:\/\/doi.org\/10.1007\/s10143-024-03107-3","journal-title":"Neurosurg Rev"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06574-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-025-06574-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06574-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:46:00Z","timestamp":1748839560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-025-06574-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6574"],"URL":"https:\/\/doi.org\/10.1007\/s00701-025-06574-9","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"160"}}